Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2019-nCoV (COVID-19)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04988152
What this trial is testing

Investigate the PK, Safety, and Tolerability of Sotrovimab vs Placebo Administered IV or IM in Japanese and Caucasian Participants

Who this might be right for
Covid19
Vir Biotechnology, Inc. 48
Testing effectiveness (Phase 2)Study completedNCT04649021
What this trial is testing

Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b2) in Chinese Healthy Population

Who this might be right for
SARS-CoV-2
BioNTech SE 960
Not applicableStudy completedNCT04351503
What this trial is testing

A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City; COVID-19

Who this might be right for
SARS Coronavirus (SARS-CoV-2) Infection
University Hospital, Basel, Switzerland 126,586
Testing effectiveness (Phase 2)Study completedNCT04276688
What this trial is testing

Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment

Who this might be right for
Novel Coronavirus Infection
The University of Hong Kong 127
Not applicableWithdrawnNCT04285190
What this trial is testing

The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19

Who this might be right for
Coronavirus Disease 2019Novel Coronavirus Pneumonia
Tasly Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Study completedNCT05438602
What this trial is testing

Learn About the Study Medicines (Nirmatrelvir Plus Ritonavir) in People Aged 12 Years or Older With COVID-19 and a Compromised Immune System

Who this might be right for
COVID-19
Pfizer 158
Not applicableStudy completedNCT05089045
What this trial is testing

Immunogenicity and Safety Evaluation of Recombinant Novel Coronavirus Vaccine (CHO Cells) in Enhancing Immunity

Who this might be right for
Coronavirus Disease 2019
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 360
Not applicableStudy completedNCT05594147
What this trial is testing

An Observational Study, Called ROCURS, to Learn About COVID-19 Related Outcomes in People With Cancer Who Are Treated With Tyrosine Kinase Inhibitors (TKIs) Including Regorafenib or Sorafenib

Who this might be right for
Malignant Solid TumorsCoronavirus Disease 2019 (COVID-19)SARS-CoV-2 Infection
Bayer 4,103
Testing effectiveness (Phase 2)Study completedNCT04346199
What this trial is testing

Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.

Who this might be right for
COVID-19
AstraZeneca 177
Not applicableStudy completedNCT06638957
What this trial is testing

Impact of the COVID-19 Pandemic on Oncologic Outcomes in Colorectal Cancer

Who this might be right for
Colorectal CarcinomaCOVID 19
In Ja Park 14,951
Large-scale testing (Phase 3)UnknownNCT04434248
What this trial is testing

An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19

Who this might be right for
COVID-19
Chromis LLC 330
Early research (Phase 1)Study completedNCT04483375
What this trial is testing

Safety, Tolerability and Pharmacokinetics of SCTA01, an Anti-SARS-CoV-2 Monoclonal Antibody, in Healthy Chinese Subjects

Who this might be right for
Coronavirus Disease 2019(COVID-19)
Sinocelltech Ltd. 33
Not applicableStudy completedNCT05228639
What this trial is testing

COVID-19 Surveillance in Rural Mozambique for Prompt and Effective Response

Who this might be right for
COVID-19
Centro de Investigacao em Saude de Manhica 6,494
Large-scale testing (Phase 3)UnknownNCT05128643
What this trial is testing

Clinical Study on the Immune Program of Recombinant Novel Coronavirus（COVID-19) Vaccine (CHO Cell)

Who this might be right for
Coronavirus Disease 2019
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 300
Testing effectiveness (Phase 2)Ended earlyNCT04834908
What this trial is testing

Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection

Who this might be right for
SARS-CoV-2 Infection
Bharat Serums and Vaccines Limited 7
Not applicableStudy completedNCT04357340
What this trial is testing

The Effects of Pulmonary Physiotherapy Treatments on Patients With COVID-19

Who this might be right for
Covid-19PneumoniaSARS Pneumonia
Tehran University of Medical Sciences 40
Early research (Phase 1)Study completedNCT05142306
What this trial is testing

A COVID-19 Study to Evaluate Safety and PK of COVID-HIG Administered Through IM, SC, or IV Routes to SARS-CoV-2 Uninfected Adults

Who this might be right for
SARS-CoV-2 Infection
Emergent BioSolutions 23
Testing effectiveness (Phase 2)UnknownNCT04356508
What this trial is testing

COVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1

Who this might be right for
COVID-19SARS-CoV-22019-nCoV+1 more
Dr Gerry Gin Wai Kwok 15
Not applicableStudy completedNCT04375761
What this trial is testing

COVID-19: Human Epidemiology and Response to SARS-CoV-2

Who this might be right for
Coronavirus Disease 2019 (COVID-19)SARS-CoV-2
National Institute of Allergy and Infectious Diseases (NIAID) 5,599
Testing effectiveness (Phase 2)UnknownNCT04396067
What this trial is testing

Aerosol Combination Therapy of All-trans Retinoic Acid and Isotretinoin as A Novel Treatment for Inducing Neutralizing Antibodies in COVID -19 Infected Patients Better Than Vaccine : An Innovative Treatment

Who this might be right for
COVID-19
Kafrelsheikh University 360
Next Page